SERPINC1 and COVID-19: Fibrin degradation products (FDP), Prothrombin time (PT) and D-dimer are predictive biomarkers for increased mortality, and antithrombin III (ATIII) is a prognostic biomarker for increased survival of ICU patients, according to a coagulation parameter analysis of samples taken from COVID-19-affected ICU patients [146].